Barbora Weinbergerová

Masaryk University — Czech Republic

Medicine · Health Sciences

24h-index2.0kcitations160works14.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Antifungal resistance and susceptibility(49), Fungal Infections and Studies(35), COVID-19 Clinical Research Studies(24), Acute Myeloid Leukemia Research(22), SARS-CoV-2 and COVID-19 Research(20)

Publications157 total

Single versus double “7+3” induction with 60 versus 90 mg/m2 daunorubicin in newly diagnosed AML: Does it matter for NPM1 MRD?
Blood·2025
Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients
Leukemia·2025· 3 citedOpen Access
Germline Jak2-R1063H mutation interferes with normal hematopoietic development and increases risk of thrombosis and leukemic transformation
Leukemia·2025· 2 citedOpen Access
Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis
Leukemia·2025· 3 citedOpen Access
Gastrointestinal toxicity of gemtuzumab ozogamicin: real-life data from the AMLCG, SAL, and CELL study groups
Blood Advances·2025· 3 citedOpen Access
P-2271. Unraveling the Past: Analyzing the Effects of COVID-19 on Hematological Malignancy Patients - Observations from 2020 to 2022
Open Forum Infectious Diseases·2025Open Access
Clinical and Prognostic Significance of Additional Chromosomal Abnormalities at Diagnosis of Chronic Myeloid Leukemia
American Journal of Hematology·2025Open Access
Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023–2024: <scp>EPICOVIDEHA</scp>‐<scp>EPIFLUEHA</scp> Report
American Journal of Hematology·2024· 7 citedOpen Access
Successful treatment of relapsed Waldenström’s macroglobulinemia with proteasome inhibitors (bortezomib and subsequently ixazomib) in combination with rituximab and dexamethasone. A case report and review of the of proteasome inhibitors in Waldenström’s macroglobulinemia
Klinicka onkologie·2024Open Access
The Differential Impact of Secondary-Type Mutations in a Multinational Cohort of 5311 Intensively Treated Acute Myeloid Leukemia Patients
Blood·2024Open Access
Single or Double Induction With 7 + 3 Containing Standard or High-Dose Daunorubicin for Newly Diagnosed AML: The Randomized DaunoDouble Trial by the Study Alliance Leukemia
Journal of Clinical Oncology·2024· 14 cited
Prevalence of fungal DNAemia mediated by putatively non-pathogenic fungi in immunocompromised patients with febrile neutropenia: a prospective cohort study
Journal of Hematology & Oncology·2024· 1 citedOpen Access
Fungal infection frequency in newly diagnosed acute myeloid leukaemia patients treated with venetoclax plus azacitidine with or without antifungal prophylaxis
British Journal of Haematology·2024· 6 citedOpen Access
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
Infection·2024Open Access
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry
Haematologica·2024· 7 citedOpen Access
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
EClinicalMedicine·2024· 29 citedOpen Access
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
Infection·2024· 9 citedOpen Access
Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic: Results from the EPICOVIDEHA registry
Hematological Oncology·2023· 14 citedOpen Access
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey
Leukemia & lymphoma/Leukemia and lymphoma·2023· 9 citedOpen Access
Decoding the Historical TALE: COVID-19 Impact on Hematological Malignancy Patients - Insights from 2020 to 2022
Blood·2023Open Access
page 1 of 8Next →

Frequent Co-authors

Zdeněk Ráčil(32), Jiřı́ Mayer(26), Francesco Marchesi(22), Jon Salmanton‐García(21), Iker Falces‐Romero(20), Alberto López‐García(19), Oliver A. Cornely(19), Livio Pagano(18), Francesca Farina(18), Andreas Glenthøj(18), Raúl Córdoba(17), Jaap A. van Doesum(17), Ola Blennow(17), Martin Schönlein(17), Monia Marchetti(16), Chiara Cattaneo(16), Federico Itri(15), Marina Machado(15), Verena Petzer(15), Raquel Nunes Rodrigues(15)